Terms: = Ovarian cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
30 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
[TBL] [Abstract] [Full Text] [Related]
3. Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.
Tassi E; Bergamini A; Wignall J; Sant'Angelo M; Brunetto E; Balestrieri C; Redegalli M; Potenza A; Abbati D; Manfredi F; Cangi MG; Magliacane G; Scalisi F; Ruggiero E; Maffia MC; Trippitelli F; Rabaiotti E; Cioffi R; Bocciolone L; Candotti G; Candiani M; Taccagni G; Schultes B; Doglioni C; Mangili G; Bonini C
Front Immunol; 2023; 14():1212444. PubMed ID: 37868997
[TBL] [Abstract] [Full Text] [Related]
4. Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis.
Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Mogi K; Kajiyama H
J Gynecol Oncol; 2021 Sep; 32(5):e66. PubMed ID: 34378361
[TBL] [Abstract] [Full Text] [Related]
5. Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea.
Ouh YT; Kang D; Kim H; Lee JK; Hong JH
Sci Rep; 2021 May; 11(1):11158. PubMed ID: 34045639
[TBL] [Abstract] [Full Text] [Related]
6. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
Xia Y; Wei X; Gong H; Ni Y
BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
[TBL] [Abstract] [Full Text] [Related]
7. Pathological Significance and Prognostic Value of Surfactant Protein D in cancer.
Mangogna A; Belmonte B; Agostinis C; Ricci G; Gulino A; Ferrara I; Zanconati F; Tripodo C; Romano F; Kishore U; Bulla R
Front Immunol; 2018; 9():1748. PubMed ID: 30127783
[TBL] [Abstract] [Full Text] [Related]
8. A panel of three oxidative stress-related genes predicts overall survival in ovarian cancer patients received platinum-based chemotherapy.
Zhang J; Yang L; Xiang X; Li Z; Qu K; Li K
Aging (Albany NY); 2018 Jun; 10(6):1366-1379. PubMed ID: 29910195
[TBL] [Abstract] [Full Text] [Related]
9. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial ovarian cancer.
Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
[TBL] [Abstract] [Full Text] [Related]
10. Molecular manipulation of keratin 8/18 intermediate filaments: modulators of fas-mediated death signaling in human ovarian granulosa tumor cells.
Trisdale SK; Schwab NM; Hou X; Davis JS; Townson DH
J Ovarian Res; 2016 Feb; 9():8. PubMed ID: 26911253
[TBL] [Abstract] [Full Text] [Related]
11. Caffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis.
Gherman C; Braicu OL; Zanoaga O; Jurj A; Pileczki V; Maralani M; Drigla F; Braicu C; Budisan L; Achimas-Cadariu P; Berindan-Neagoe I
Mol Cell Biochem; 2016 Feb; 413(1-2):189-98. PubMed ID: 26838168
[TBL] [Abstract] [Full Text] [Related]
12. Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.
Mahdi H; Munkarah AR; Ali-Fehmi R; Woessner J; Shah SN; Moslemi-Kebria M
Arch Gynecol Obstet; 2015 Jul; 292(1):183-90. PubMed ID: 25549769
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.
Chen Y; Zhang L; Lv R; Zhang WQ
Asian Pac J Cancer Prev; 2013; 14(10):5883-90. PubMed ID: 24289594
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis.
Liu S; Liu C; Min X; Ji Y; Wang N; Liu D; Cai J; Li K
PLoS One; 2013; 8(11):e81050. PubMed ID: 24282568
[TBL] [Abstract] [Full Text] [Related]
15. Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers.
Hariprasad G; Hariprasad R; Kumar L; Srinivasan A; Kola S; Kaushik A
Biomarkers; 2013 Sep; 18(6):532-41. PubMed ID: 23902290
[TBL] [Abstract] [Full Text] [Related]
16. Genetic polymorphisms in the fas and fasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract] [Full Text] [Related]
17. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.
Le Page C; Marineau A; Bonza PK; Rahimi K; Cyr L; Labouba I; Madore J; Delvoye N; Mes-Masson AM; Provencher DM; Cailhier JF
PLoS One; 2012; 7(6):e38541. PubMed ID: 22685580
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.
Capper D; Berghoff AS; Magerle M; Ilhan A; Wöhrer A; Hackl M; Pichler J; Pusch S; Meyer J; Habel A; Petzelbauer P; Birner P; von Deimling A; Preusser M
Acta Neuropathol; 2012 Feb; 123(2):223-33. PubMed ID: 22012135
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis.
Espinosa I; Catasus L; Canet B; D'Angelo E; Muñoz J; Prat J
Mod Pathol; 2011 Jun; 24(6):846-54. PubMed ID: 21317880
[TBL] [Abstract] [Full Text] [Related]
20. The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.
Duiker EW; van der Zee AG; de Graeff P; Boersma-van Ek W; Hollema H; de Bock GH; de Jong S; de Vries EG
Gynecol Oncol; 2010 Mar; 116(3):549-55. PubMed ID: 19959214
[TBL] [Abstract] [Full Text] [Related]
[Next]
